![]() |
![]() |
February 19, 1999
Once again APA's annual meeting will offer much needed information on the psychiatric aspects of HIV/AIDS. The following sessions are sponsored by APA's AIDS Program Office.
Saturday to Wednesday, May 15 to 19: The AIDS Resource Center in the Exhibit Hall will feature an exhibit of national and local HIV/AIDS-related health and mental health care information. Resources will include books, newsletters, training curricula, audiotapes and videotapes, pamphlets, posters, and online services
Sunday, May 16, 12:30 p.m. to 4:30 p.m., "Residency Training Program": This program will give residents practical information on neuropsychiatric complications and treatment they can use in the care of HIV/AIDS patients. The program will begin with an overview of the resident's role in the care and treatment of HIV/AIDS patients and the issues they will face in the future. Box lunch will be provided. Reservations are required and can be made by calling (202) 682-6163.
Monday, May 17, 9 a.m. to 10:30 a.m., "Sildenafil Citrate, Sexual Function, and HIV Prevention": This component workshop will examine the clinical, psychological, and ethical issues surrounding the advent of pharmacologic agents used to treat patients with sexual dysfunction.
Monday, May 17, 11 a.m. to 12:30 p.m., "HIV/AIDS Education and Training of Psychiatrists": This issue workshop will provide a review of curriculum, discussion of training methods, and sharing of clinical experiences between panelists and the audience. An electronic audience response system will allow participants to use handsets to respond to questions posed by the panel.
Tuesday, May 18, 9 a.m. to noon, "Medical and Neuropsychiatric Dimensions of HIV Disease": Panelists will review the medical, epidemiological, and treatment issues associated with AIDS and HIV infection, the spectrum of neuropsychiatric conditions that often exist with HIV infection, and the range of effective psychopharmacological treatment approaches.
Wednesday, May 19, 9 a.m. to noon, "Psychiatric and Clinical Manifestations of HIV Disease": Panelists will review the clinical manifestations, differential diagnosis, and treatment of HIV-related mood disorders; the interaction between psychotic disorders and HIV-1 infection; and the role of psychiatrists in the biological assessment and symptom management of HIV somatic conditions.
Here is a list of other HIV/AIDS-related sessions:
Tuesday, May 18
11 a.m. to 12-30 p.m.
Scientific and Clinical Report 48: "Immunological Status Versus Depression as Predictors of Quality of Life in HIV-Infected Individuals"
2 p.m. to 5 p.m.
Symposium 21: "Group Therapy for Persons Living With HIV/AIDS
Symposium 28: "Psychiatry in the Second Decade of the HIV Pandemic"
7 p.m. to 10 p.m.
Media Presentation 33: Odo Ya! Life with AIDS"
Media Presentation 34: "Rainmakers Thailand"
Media Presentation 35: "Women and HIV: Four Stories"
Wednesday, May 19
9a.m. to 10:30 a.m.
Issue Workshop 38: "Clinical Aspects of HIV and AIDS Among Hispanics"
11 a.m. to 12:30 p.m.
Discussion Group: "Challenges in HIV Care for Psychiatrists"
Thursday, May 20
9a.m. to 10:30 a.m.
Component Worship 47: "HIV Prevention: Stigma and Names-Based Reporting"